Equillium Stock Buy Hold or Sell Recommendation
| EQ Stock | USD 1.65 0.04 2.48% |
Allowing for the 90-day total investment horizon and your above-average risk tolerance, our recommendation regarding Equillium is 'Hold'. Macroaxis provides Equillium buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding EQ positions. The advice algorithm takes into account all of Equillium's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Equillium's buy or sell advice are summarized below:
Real Value 3.23 | Target Price 8 | Hype Value 1.07 | Market Value 1.65 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Equillium given historical horizon and risk tolerance towards Equillium. When Macroaxis issues a 'buy' or 'sell' recommendation for Equillium, the advice is generated through an automated system that utilizes algorithms and statistical models.
Equillium |
Execute Equillium Buy or Sell Advice
The Equillium recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Equillium. Macroaxis does not own or have any residual interests in Equillium or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Equillium's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Hold
Market Performance | Good | Details | |
Volatility | Dangerous | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Very Weak | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Equillium Trading Alerts and Improvement Suggestions
| Equillium is way too risky over 90 days horizon | |
| Equillium may become a speculative penny stock | |
| Equillium appears to be risky and price may revert if volatility continues | |
| The company generated the yearly revenue of 36.08 M. Annual Net Loss to common stockholders was (13.34 M) with gross profit of 15.76 M. | |
| Equillium reports about 57.56 M in cash with (21.78 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.68, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Equillium has a very weak financial position based on the latest SEC disclosures | |
| Roughly 36.0% of the company shares are held by company insiders | |
| Latest headline from finance.yahoo.com: EQ Inc. Reports Profitable Fourth Quarter and 2023 Year End Financial Results |
Equillium current analysts advice
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Equillium analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Equillium analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Average Consensus Strong Buy
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.
Equillium Returns Distribution Density
The distribution of Equillium's historical returns is an attempt to chart the uncertainty of Equillium's future price movements. The chart of the probability distribution of Equillium daily returns describes the distribution of returns around its average expected value. We use Equillium price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Equillium returns is essential to provide solid investment advice for Equillium.
| Mean Return | 1.55 | Value At Risk | -10.8 | Potential Upside | 20.33 | Standard Deviation | 11.02 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Equillium historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Equillium Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Equillium is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Equillium backward and forwards among themselves. Equillium's institutional investor refers to the entity that pools money to purchase Equillium's securities or originates loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Citadel Advisors Llc | 2023-09-30 | 47 K | Integrated Wealth Concepts Llc | 2023-12-31 | 40 K | Northern Trust Corp | 2023-12-31 | 35.2 K | Millennium Management Llc | 2023-12-31 | 24.7 K | Capital Cs Group, Llc | 19 K | Jane Street Group, Llc | 2023-12-31 | 12 K | Tower Research Capital Llc | 2023-12-31 | 9.4 K | Adar1 Capital Management Llc | 2023-12-31 | 6.5 K | Blackrock Inc | 2023-12-31 | 3.8 K | Decheng Capital Llc | 2023-12-31 | 4.4 M | Vanguard Group Inc | 2023-12-31 | 836.9 K |
Equillium Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Investments | (2.1M) | (18.6M) | 27.5M | 18.7M | 7.8M | 8.2M | |
| Change In Cash | (15.3M) | 10.8M | 26.4M | 8.7M | (35.9M) | (34.1M) | |
| Depreciation | 23K | 45K | 72K | 118K | 126K | 132.3K | |
| Capital Expenditures | 74K | 202K | 57K | 279K | 50K | 47.5K | |
| Net Income | (25.6M) | (29.8M) | (39.1M) | (62.4M) | (13.3M) | (14.0M) | |
| End Period Cash Flow | 13.2M | 24.0M | 50.4M | 59.1M | 23.2M | 32.3M | |
| Change To Netincome | 2.2M | 3.6M | 4.7M | 28.3M | 32.5M | 34.1M | |
| Free Cash Flow | (23.0M) | (24.8M) | (32.1M) | (9.0M) | (21.8M) | (22.9M) | |
| Other Non Cash Items | 47K | 341K | 237K | 48.7M | (10.2M) | (9.7M) |
Equillium Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Equillium or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Equillium's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Equillium stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | 1.14 | |
β | Beta against NYSE Composite | 5.33 | |
σ | Overall volatility | 11.22 | |
Ir | Information ratio | 0.13 |
Equillium Volatility Alert
Equillium is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Equillium's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Equillium's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Equillium Fundamentals Vs Peers
Comparing Equillium's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Equillium's direct or indirect competition across all of the common fundamentals between Equillium and the related equities. This way, we can detect undervalued stocks with similar characteristics as Equillium or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Equillium's fundamental indicators could also be used in its relative valuation, which is a method of valuing Equillium by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Equillium to competition |
| Fundamentals | Equillium | Peer Average |
| Return On Equity | -0.49 | -0.31 |
| Return On Asset | -0.14 | -0.14 |
| Profit Margin | (0.37) % | (1.27) % |
| Operating Margin | (0.35) % | (5.51) % |
| Current Valuation | 16.72 M | 16.62 B |
| Shares Outstanding | 35.25 M | 571.82 M |
| Shares Owned By Insiders | 36.42 % | 10.09 % |
| Shares Owned By Institutions | 21.76 % | 39.21 % |
| Number Of Shares Shorted | 394.47 K | 4.71 M |
| Price To Earning | (6.70) X | 28.72 X |
| Price To Book | 2.95 X | 9.51 X |
| Price To Sales | 1.81 X | 11.42 X |
| Revenue | 36.08 M | 9.43 B |
| Gross Profit | 15.76 M | 27.38 B |
| EBITDA | (14.4 M) | 3.9 B |
| Net Income | (13.34 M) | 570.98 M |
| Cash And Equivalents | 57.56 M | 2.7 B |
| Cash Per Share | 1.68 X | 5.01 X |
| Total Debt | 824 K | 5.32 B |
| Debt To Equity | 0.29 % | 48.70 % |
| Current Ratio | 3.98 X | 2.16 X |
| Book Value Per Share | 0.64 X | 1.93 K |
| Cash Flow From Operations | (21.78 M) | 971.22 M |
| Short Ratio | 1.53 X | 4.00 X |
| Earnings Per Share | (0.38) X | 3.12 X |
| Target Price | 7.0 | |
| Number Of Employees | 44 | 18.84 K |
| Beta | 1.67 | -0.15 |
| Market Capitalization | 56.76 M | 19.03 B |
| Total Asset | 50.53 M | 29.47 B |
| Retained Earnings | (185.74 M) | 9.33 B |
| Working Capital | 21.78 M | 1.48 B |
| Current Asset | 60.04 M | 9.34 B |
Note: Acquisition by Zedelmayer Christine of 8334 shares of Equillium at 2.45 subject to Rule 16b-3 [view details]
Equillium Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Equillium . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 4239.6 | |||
| Daily Balance Of Power | 0.3077 | |||
| Rate Of Daily Change | 1.02 | |||
| Day Median Price | 1.65 | |||
| Day Typical Price | 1.65 | |||
| Price Action Indicator | 0.025 | |||
| Period Momentum Indicator | 0.04 |
About Equillium Buy or Sell Advice
When is the right time to buy or sell Equillium? Buying financial instruments such as Equillium Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.| 2021 | 2022 | 2023 | 2024 (projected) | Short and Long Term Debt Total | 10.0M | 10.2M | 824K | 782.8K | Total Assets | 85.4M | 78.4M | 50.5M | 67.5M |
Use Investing Ideas to Build Portfolios
In addition to having Equillium in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Banks Thematic Idea Now
Banks
Large and small money and credit banks and credit services. The Banks theme has 39 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Banks Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Equillium Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. To learn how to invest in Equillium Stock, please use our How to Invest in Equillium guide.You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Complementary Tools for Equillium Stock analysis
When running Equillium's price analysis, check to measure Equillium's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Equillium is operating at the current time. Most of Equillium's value examination focuses on studying past and present price action to predict the probability of Equillium's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Equillium's price. Additionally, you may evaluate how the addition of Equillium to your portfolios can decrease your overall portfolio volatility.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Stocks Directory Find actively traded stocks across global markets | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |
Is Equillium's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Equillium. If investors know Equillium will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Equillium listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.38) | Revenue Per Share 1.039 | Quarterly Revenue Growth (0.42) | Return On Assets (0.14) | Return On Equity (0.49) |
The market value of Equillium is measured differently than its book value, which is the value of Equillium that is recorded on the company's balance sheet. Investors also form their own opinion of Equillium's value that differs from its market value or its book value, called intrinsic value, which is Equillium's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Equillium's market value can be influenced by many factors that don't directly affect Equillium's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Equillium's value and its price as these two are different measures arrived at by different means. Investors typically determine if Equillium is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Equillium's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.